Kalle Alanen - UTU Research Portal

Kalle Alanen

- Docent,
Faculty of Medicine (University of Turku)

kaalan@utu.fi

Kiinamyllynkatu 10

Turku

Publications

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)
- Cancers
Yu Lan, Toriseva Mervi, Afshan Syeda, Cangiano Mario, Fey Vidal, Erickson Andrew, Seikkula Heikki, Alanen Kalle, Taimen Pekka, Ettala Otto, Nurmi Martti, Boström Peter J, Kallajoki Markku, Tuomela Johanna, Mirtti Tuomas, Beumer Inès J, Nees Matthias, Härkönen Pirkko
(A1 Refereed original research article in a scientific journal)
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy (2016)
- International Journal of Cancer
Yu L, Toriseva M, Tuomala M, Seikkula H, Elo T, Tuomela J, Kallajoki M, Mirtti T, Taimen P, Bostrom PJ, Alanen K, Nurmi M, Nees M, Harkonen P
(A1 Refereed original research article in a scientific journal)
Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study (2015)
- Journal of Nuclear Medicine
Kauhanen S, Rinta-Kiikka I, Kemppainen J, Gronroos J, Kajander S, Seppanen M, Alanen K, Gullichsen R, Nuutila P, Ovaska J
(A1 Refereed original research article in a scientific journal)
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions (2015)
- International Journal of Cancer
Saeed K, Ostling P, Bjorkman M, Mirtti T, Alanen K, Vesterinen T, Sankila A, Lundin J, Lundin M, Rannikko A, Nordling S, Mpindi JP, Kohonen P, Iljin K, Kallioniemi O, Rantala JK
(A1 Refereed original research article in a scientific journal)
Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy (2015)
- Journal of Magnetic Resonance Imaging
Ivan Jambor, Esa Kähkönen, Pekka Taimen, Harri Merisaari, Jani Saunavaara, Kalle Alanen, Branislav Obsitnik, Heikki Minn, Viera Lehotska, Hannu J. Aronen
(A1 Refereed original research article in a scientific journal)
Lanthanide chelate complementation and hydrolysis enhanced luminescent chelate in real-time reverse transcription polymerase chain reaction assays for KLK3 transcripts (2014)
- Analytical Biochemistry
Alinezhad S, Vaananen RM, Lehmusvuori A, Karhunen U, Soukka T, Kahkonen E, Taimen P, Alanen K, Pettersson K
(A1 Refereed original research article in a scientific journal)
Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation (2014)
- Molecular Cancer Therapeutics
Gu L, Talati P, Vogiatzi P, Romero-Weaver AL, Abdulghani J, Liao Z, Leiby B, Hoang DT, Mirtti T, Alanen K, Zinda M, Huszar D, Nevalainen MT
(A1 Refereed original research article in a scientific journal)
Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens (2013)
- Clinical Biochemistry
Vaananen RM, Lilja H, Cronin A, Kauko L, Rissanen M, Kauko O, Kekki H, Vidback S, Nurmi M, Alanen K, Pettersson K
(A1 Refereed original research article in a scientific journal)
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy (2013)
- Human Pathology
Mirtti T, Leiby BE, Abdulghani J, Aaltonen E, Pavela M, Mamtani A, Alanen K, Egevad L, Granfors T, Josefsson A, Stattin P, Bergh A, Nevalainen MT
(A1 Refereed original research article in a scientific journal)
High-throughout transriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer (2012)
- PLoS ONE
Paula Vainio, John-Patrick Mpindi, Pekka Korhonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin
(A1 Refereed original research article in a scientific journal)
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer (2011)
- American Journal of Pathology
Vainio Paula, Gupta Santosh, Ketola Kirsi, Mirtti Tuomas, Mpindi John-Patrik, Kohonen Pekka, Fey Vidal, Perälä Merja, Smit Frank, Verhaegh Gerald, Schalken Jack, Alanen Kalle A, Kallioniemi Olli, Iljin Kristiina
(A1 Refereed original research article in a scientific journal)
Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer (2011)
- Oral Oncology
Bello Ibrahim O, Vered Marilena, Dayan Dan, Dobriyan Alex, Yahalom Ran, Alanen Kalle, Nieminen Pentti, Kantola Saara, Läärä Esa, Salo Tuula
(A1 Refereed original research article in a scientific journal)
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay (2011)
- International Journal of Cancer
Rappu P, Nylund C, Ristiniemi N, Kulpakko J, Vihinen P, Hernberg M, Mirtti T, Alanen K, Kallajoki M, Vuoristo MS, Pyrhonen S, Heino J
(A1 Refereed original research article in a scientific journal)
Intact and Internally Cleaved Free Prostate-Specific Antigen in Patients With Prostate Cancer With Different Pathologic Stages and Grades (2011)
- Urology
Peltola MT, Niemela P, Vaisanen V, Viitanen T, Alanen K, Nurmi M, Pettersson K
(A1 Refereed original research article in a scientific journal)
Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma (2011)
- Oral Oncology
Kokko Linda-Lotta, Hurme Saija, Maula Sanna-Mari, Alanen Kalle, Grénman Reidar, Kinnunen Ilpo, Ventelä Sami
(A1 Refereed original research article in a scientific journal)
Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a novel immunoassay (2010)
- Journal of Investigative Dermatology
Rappu P, Nylund C, Ristiniemi N, Kulpakko J, Vihinen P, Hernberg M, Alanen K, Kallajoki M, Pyrhönen S, Heino J
(Other publication)
Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy. (2010)
- Journal of Nuclear Medicine
Jambor Ivan, Borra Ronald, Kemppainen Jukka, Lepomäki Virva, Parkkola Ritta, Dean Kirsti, Alanen Kalle, Arponen Evellina, Nurmi Martti, Aronen Hannu Juhani, Minn Heikki
(A1 Refereed original research article in a scientific journal)
FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells (2010)
- Cancer Research
Gupta S, Iljin K, Sara H, Mpindi JP, Mirtti T, Vainio P, Rantala J, Alanen K, Nees M, Kallioniemi O
(A1 Refereed original research article in a scientific journal)
N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells (2010)
- International Journal of Biochemistry and Cell Biology
Dagvadorj A, Tan S H, Liao Z, Xie J, Nurmi M, Alanen K, Rui H, Mirtti T, Nevalainen M T
(A1 Refereed original research article in a scientific journal)
Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo (2010)
- Endocrine-Related Cancer
Gu L, Vogiatzi P, Puhr M, Dagvadorj A, Lutz J, Ryder A, Addya S, Fortina P, Cooper C, Leiby B, Dasgupta A, Hyslop T, Bubendorf L, Alanen K, Mirtti T, Nevalainen M T
(A1 Refereed original research article in a scientific journal)